Caris Life Sciences CAI
NASDAQ CAI
$28.35 -2.28 (-7.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Caris Life Sciences (CAI) Return on Equity [ROE] (2025 - 2026)

Updated

Caris Life Sciences (CAI) reported Return on Equity [ROE] of 17.74% for Q2 2026, up 11.94 percentage points from the prior quarter.

Analysis

Caris Life Sciences (CAI) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

Dating back to Q3 2025, Caris Life Sciences' Return on Equity [ROE] record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q2 2026 came in at 5.80% (Q1 2026), -12.90% (Q4 2025) and -40.16% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn - -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn -10.70%
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn 14.38%
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn 11.58%
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn -
6 Tenet Healthcare 20.58 Bn 11.72 Bn - 47.84%
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn -57.32%
8 Encompass Health 11.99 Bn 12.46 Bn - 24.83%
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn 18.16%
10 Caris Life Sciences 8.66 Bn 5.48 Bn 179.60 Mn 17.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.74%
Mar 31, 2026 5.80%
Dec 31, 2025 -12.90%
Sep 30, 2025 -40.16%
API Access

Caris Life Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CAI&period=max&api_key=YOUR_API_KEY